Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Current Oncology Reports|March 18, 2017
Current Management Strategy for Metastatic Renal Cell Carcinoma and Future DirectionsHussein Merza, Marijo BilusicCancer Management and Research|September 5, 2020
Pembrolizumab in Combination with Axitinib as First-Line Treatment for Patients with Renal Cell Carcinoma (RCC): Evidence to DateVincent Chau, Marijo BilusicExpert Review of Anticancer Therapy|March 3, 2025
Overcoming common emerging barriers to effective neoadjuvant immunotherapiesSophia Sokol, Marijo BilusicCancer Immunology, Immunotherapy : CII|November 29, 2011
Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccinesMarijo Bilusic, James L GulleyHematology/Oncology Clinics of North America|March 6, 2019
Cancer VaccinesPeter J DeMaria, Marijo BilusicAmerican Journal of Therapeutics|February 15, 2011
Therapeutic cancer vaccines: the latest advancement in targeted therapyMarijo Bilusic, Ravi A MadanAsian Journal of Andrology|April 25, 2014
Anti-angiogenesis in prostate cancer: knocked down but not outMarijo Bilusic, Yu-Ning WongBMC Nephrology|November 24, 2016
Nivolumab-associated acute glomerulonephritis: a case report and literature reviewKyungsuk Jung, Xu Zeng, Marijo BilusicVaccine|July 12, 2011
Immunotherapy in prostate cancer: emerging strategies against a formidable foeMarijo Bilusic, Christopher Heery, Ravi A MadanThe Journal of Clinical Investigation|December 1, 2022
Is androgen receptor activity in metastatic prostate cancer a good biomarker for bipolar androgen therapy?Nahuel Peinetti, Marijo Bilusic, Kerry L BurnsteinPageof 7